Scientists have developed a test that uses cells from a single donor’s blood to predict whether a new drug will cause a severe reaction in humans.
The test could avert disasters like the 2006 trial of the drug TGN1412, which led to six healthy young men being admitted to intensive care with multiple organ failure. The volunteers receiving TGN1412 experienced a catastrophic inflammatory reaction called a cytokine storm.
Cytokine storm reactions are a particular worry for new biological therapies, or “biologics”, which use biological material such as antibodies. Many blockbuster drugs such as the cancer drugs Herceptin and Avastin are biologics, as are around a third of medicines in the pharmaceutical pipeline. Because these medicines are specific to humans, they can cause severe reactions that don’t materialise in animal studies, so tests on human cells are essential.
However, cytokine storm side effects are hard to predict with tests were just one cell type is used, since they depend on interactions between blood cells and endothelial cells, which form the lining of blood vessels. But because endothelial cells are deep within the body, they are normally only grown from tissue removed in surgery or post mortem, or from umbilical vessels after birth.
Because of this, current tests use endothelial cells taken from vessels of one donor, and white blood cells from a different donor. When cells from two different donors are used, one may have an immune reaction to the other, meaning the system is already primed for inflammation before the drug is added. This can result in the test falsely showing a severe immune reaction to a drug that is safe.
Researchers at Imperial College London got around this problem by isolating stem cells from the blood of a volunteer, and using them to grow endothelial cells in a dish. They then took white blood cells which they added to the donor’s own endothelial cells to recreate the unique conditions found in their blood vessels. When TGN1412 was added to the test tube, the mixture of cells released a cytokine storm, as would happen inside the body.
The new method is better as it only requires blood from one donor and doesn’t mix cells from different people, with the advantage of making a more reliable test.
Professor Jane Mitchell, from the National Heart and Lung Institute at Imperial College London, who led the study, said: “As biological therapies become more mainstream, it’s more likely that drugs being tested on humans for the first time will have unexpected and potentially catastrophic effects. We’ve used adult stem cell technology to develop a laboratory test that could prevent another disaster like the TGN1412 trial.
“Drug companies have the technical capacity to start using this test now, but we’re working on developing an off-the-shelf kit which will make it easy to use on a large scale.”
Dr Daniel Reed, the first author on the study, said: ”A further benefit of this new technology is that personalised therapies can be tested to see how safe and effective they will be for an individual.”
The Latest on: Personalised therapies
via Google News
The Latest on: Personalised therapies
- Cancer Gene Therapy Market Growth Opportunities, Trends by Manufacturers, Regions, Application and Forecast to 2024on September 6, 2019 at 8:24 am
rising cancer prevalence will increase demand for gene therapy as the effective personalized treatment choice. According to WHO, cancer incidence is projected to rise by 50% to reach 15 million by the ...
- Novartis, Spark gene therapies win a boost with soup-to-nuts Cigna coverageon September 6, 2019 at 8:20 am
The new gene therapy program will bring together services from many of Cigna's business segments, including the pharmacy benefit manager Express Scripts, to offer patients “personalized and expert ...
- Global Radiation Therapy Market Research Report 2019 Analysis and Forecast 2024on September 6, 2019 at 6:35 am
Ltd., and many others. Top Industry News In August 2019, a new model called Genomically Adjusted Radiation Dose (GARD) has been developed to optimize and deliver personalized radiation therapy to ...
- Cigna Health Services Business Pioneers an Innovative Solution to Affordably Bring Life-Changing Therapies to Patientson September 5, 2019 at 4:46 am
Additional therapies may be added in the future ... affordability and access to quality care through integrated capabilities and connected, personalized solutions that advance whole person health. All ...
- Achilles Therapeutics raises $120M in Series B round for cancer cell therapyon September 4, 2019 at 9:16 am
Achilles’ approach involves personalized T-cell therapies that target clonal neoantigens, which are protein markers unique to each patient that are present on the surface of cancer cells.
- Vineti and Cryoport Collaborate to Bring Integrated Solutions to the Global Regenerative Therapy Marketon September 4, 2019 at 5:00 am
Vineti’s supply chain orchestration (SCO) platform, the only independent digital solution serving both clinical and commercial advanced therapy products, will help clients ensure that there is tight, ...
- Restorative Therapies Announces New Branding and Website to Reflect Commitment to Neuro Rehab and Critical Care Marketson September 4, 2019 at 4:20 am
For more information please visit https://restorative-therapies.com/. SOURCE Restorative Therapies Your Personalized Market Center ...
- Personalized treatment for ARDS: Ready for prime time?on September 3, 2019 at 1:12 pm
Can we improve by tailoring therapy according to phenotype ... and nonfocal disease are very different and we do not yet have the power determine whether personalized treatment does or does not make a ...
- Liquid biopsy imporves personalized medicine for canceron August 30, 2019 at 2:40 am
The method has been reported to the journal Science Translational Medicine, with the research paper titled "Personalized circulating tumor DNA analysis to detect residual disease after neoadjuvant ...
- Life Skills Autism Academy opening in Plano plans to provide one-on-one therapyon August 27, 2019 at 2:36 pm
One in 59 children are born with autism spectrum disorder in the U.S., and many go through their early years without personalized therapy that studies show sets them up to thrive. Life Skills Autism ...
via Bing News